Prostatis Group’s Fidelity MSCI Health Care Index ETF FHLC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-10,036
Closed -$10K 146
2023
Q2
$10K Buy
+10,036
New +$629K ﹤0.01% 250
2020
Q4
Sell
-20,893
Closed -$1.1M 78
2020
Q3
$1.1M Buy
20,893
+9,280
+80% +$485K 1.04% 30
2020
Q2
$578K Buy
11,613
+2,596
+29% +$126K 1.16% 30
2020
Q1
$388K Sell
9,017
-25,944
-74% -$1.23M 0.55% 30
2019
Q4
$1.74M Buy
+34,961
New +$1.62M 1.57% 20

Other funds holding FHLC

Prostatis Group's FHLC Position: Q3 2023 in Review

Prostatis Group sold out of Fidelity MSCI Health Care Index ETF (FHLC) in Q3 2023, closing a stake of 10,036 shares — an estimated $10K sold.

Prostatis Group first reported a position in FHLC in Q4 2019 and held it in 5 quarters. The position peaked at $1.74M in Q4 2019. 294 funds tracked by Wall St. Rank hold FHLC as of Q3 2023.

  • Prostatis Group reported no remaining Fidelity MSCI Health Care Index ETF position as of Q3 2023 after selling out during the quarter.
  • Prostatis Group sold 10,036 Fidelity MSCI Health Care Index ETF shares in Q3 2023, an estimated $10K.
  • Prostatis Group first reported a position in Fidelity MSCI Health Care Index ETF in Q4 2019 and held it in 5 quarters.
  • Prostatis Group's Fidelity MSCI Health Care Index ETF position peaked at $1.74M in Q4 2019.
  • 294 funds tracked by Wall St. Rank held Fidelity MSCI Health Care Index ETF as of Q3 2023.

Based on Prostatis Group's 13F filing for Q3 2023, filed 21 Mar 2025.